{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:57:24Z","timestamp":1793120244492,"version":"4.5.0"},"reference-count":40,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1136\/jnnp-2017-315985","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T20:50:22Z","timestamp":1507668622000},"page":"1060-1064","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":133,"title":["Dopamine dysregulation syndrome in Parkinson\u2019s disease: a systematic review of published cases"],"prefix":"10.1136","volume":"88","author":[{"given":"Nicola","family":"Warren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cullen","family":"O\u2019Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Siskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"key-10.1136\/jnnp-2017-315985-1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2017-315985-2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(03)00529-5","article-title":"Compulsive use of dopamine replacement therapy in Parkinson\u2019s disease: reward systems gone awry?","volume":"2","author":"Lawrence","year":"2003","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2017-315985-3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.drugalcdep.2004.06.005","article-title":"Recognition of a dopamine replacement therapy dependence syndrome in Parkinson\u2019s disease: a pilot study","volume":"76","author":"Bearn","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"key-10.1136\/jnnp-2017-315985-4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mds.20288","article-title":"Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson\u2019s disease","volume":"20","author":"Pezzella","year":"2005","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2017-315985-5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jnnp-2012-303988","article-title":"Dopamine dysregulation syndrome in Parkinson\u2019s disease: from clinical and neuropsychological characterisation to management and long-term outcome","volume":"85","author":"Cilia","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2017-315985-6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jns.2011.07.012","article-title":"Dopaminergic dysregulation syndrome in Parkinson\u2019s disease","volume":"310","author":"Katzenschlager","year":"2011","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2017-315985-7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.20822","article-title":"Compulsive drug use linked to sensitized ventral striatal dopamine transmission","volume":"59","author":"Evans","year":"2006","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2017-315985-8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","article-title":"Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management","volume":"23","author":"O\u2019Sullivan","year":"2009","journal-title":"CNS Drugs"},{"key":"key-10.1136\/jnnp-2017-315985-9","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2017-315985-10","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"key-10.1136\/jnnp-2017-315985-11","volume-title":"Living with parkinson\u2019s disease: an updated economic analysis 2014 report for Parkinson\u2019s Australia","author":"Economics","year":"2015"},{"key":"key-10.1136\/jnnp-2017-315985-12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afp223","article-title":"Ageing, neurodegeneration and Parkinson\u2019s disease","volume":"39","author":"Hindle","year":"2010","journal-title":"Age Ageing"},{"key":"key-10.1136\/jnnp-2017-315985-13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson\u2019s disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2017-315985-14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ana.20878","article-title":"Dopamine dysregulation syndrome in Parkinson\u2019s disease patients: from reward to penalty","volume":"59","author":"Bonci","year":"2006","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2017-315985-15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/FBP.0b013e32833109a0","article-title":"Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson\u2019s disease","volume":"20","author":"Fenu","year":"2009","journal-title":"Behav Pharmacol"},{"key":"key-10.1136\/jnnp-2017-315985-16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1360-0443.95.8s2.19.x","article-title":"The psychology and neurobiology of addiction: an incentive-sensitization view","volume":"95\u00a0","author":"Robinson","year":"2000","journal-title":"Addiction"},{"key":"key-10.1136\/jnnp-2017-315985-17","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.1136\/jnnp-2017-315985-18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1037\/a0021591","article-title":"Sex differences in impulsivity: a meta-analysis","volume":"137","author":"Cross","year":"2011","journal-title":"Psychol Bull"},{"key":"key-10.1136\/jnnp-2017-315985-19","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","article-title":"Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease","volume":"65","author":"Evans","year":"2005","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2017-315985-20","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2017-315985-21","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/brain\/123.11.2297","article-title":"Dyskinesias and motor fluctuations in Parkinson\u2019s disease. A community-based study","volume":"123\u00a0","author":"Schrag","year":"2000","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2017-315985-22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.pnpbp.2011.02.002","article-title":"Behavioral, neuropsychiatric and cognitive disorders in Parkinson\u2019s disease patients with and without motor complications","volume":"35","author":"Solla","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key-10.1136\/jnnp-2017-315985-23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neubiorev.2010.06.007","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson\u2019s disease: consequences of l-DOPA treatment","volume":"35","author":"Eskow Jaunarajs","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"key-10.1136\/jnnp-2017-315985-24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/WNF.0b013e3181634ea6","article-title":"Dopamine dysregulation syndrome and levodopa-induced dyskinesias in Parkinson disease: common consequences of anomalous forms of neural plasticity","volume":"32","author":"Linazasoro","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"key-10.1136\/jnnp-2017-315985-25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2017-315985-26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mds.22898","article-title":"Compulsive use of dopaminergic drug therapy in Parkinson\u2019s disease: reward and anti-reward","volume":"25","author":"Evans","year":"2010","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2017-315985-27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0404.1993.tb04068.x","article-title":"\u201cPanic attacks\u201d\u00a0in Parkinson\u2019s disease","volume":"87","author":"Vazquez","year":"1993","journal-title":"Acta neurologica scandinavica"},{"key":"key-10.1136\/jnnp-2017-315985-28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00207454.2011.633722","article-title":"Addiction-like manifestations and Parkinson\u2019s disease: a large single center 9-year experience","volume":"122","author":"Limotai","year":"2012","journal-title":"Int J Neurosci"},{"key":"key-10.1136\/jnnp-2017-315985-29","article-title":"Alcohol Consumption, Types of Alcohol, and Parkinson\u2019s Disease","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"key-10.1136\/jnnp-2017-315985-30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s40265-016-0600-5","article-title":"Psychosis in Parkinson\u2019s Disease: Epidemiology, Pathophysiology, and Management","volume":"76","author":"Chang","year":"2016","journal-title":"Drugs"},{"key":"key-10.1136\/jnnp-2017-315985-31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00415-006-0388-4","article-title":"Relationship between age and subtypes of psychotic symptoms in Parkinson\u2019s disease","volume":"254","author":"Kiziltan","year":"2007","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2017-315985-32","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S1353-8020(11)70579-X","article-title":"Improvement of impulsive control disorders in Parkinson\u2019s Disease with jejunal levodopa infusion","volume":"18","author":"Lopez-Valdes","year":"2012","journal-title":"Parkinsonism & Related Disorders"},{"key":"key-10.1136\/jnnp-2017-315985-33","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jocn.2008.12.010","article-title":"Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson\u2019s disease","volume":"16","author":"Lim","year":"2009","journal-title":"J Clin Neurosci"},{"key":"key-10.1136\/jnnp-2017-315985-34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease","volume":"339","author":"Limousin","year":"1998","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2017-315985-35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/jnnp-2012-302387","article-title":"Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson\u2019s disease","volume":"84","author":"Eusebio","year":"2013","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"key-10.1136\/jnnp-2017-315985-36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/aws078","article-title":"Subthalamic stimulation in Parkinson\u2019s disease: restoring the balance of motivated behaviours","volume":"135","author":"Lhomm\u00e9e","year":"2012","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2017-315985-37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029768","article-title":"Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome","volume":"7","author":"Moum","year":"2012","journal-title":"PLoS One"},{"key":"key-10.1136\/jnnp-2017-315985-38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.parkreldis.2011.03.003","article-title":"Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson\u2019s disease","volume":"17","author":"Hicks","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"key-10.1136\/jnnp-2017-315985-39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00415-012-6669-1","article-title":"Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson\u2019s disease","volume":"260","author":"Sriram","year":"2013","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2017-315985-40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2017-315985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T13:16:18Z","timestamp":1719494178000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2017-315985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,28]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/jnnp-2017-315985"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2017-315985","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731966905.793537690","asserted-by":"object"}]},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]}}}